Leslie Hudson
Nessuna posizione attualmente
Profilo
Leslie Hudson served as Vice President-Discovery Research at GSK Plc from 1988 to 1994.
From 2005 to 2006, he was President & Chief Executive Officer at DOV Pharmaceutical, Inc. He served as President, Co-Chief Executive & Operating Officer at Sarepta Therapeutics, Inc. from 2008 to 2010.
Hudson was also Senior Vice President-Research & Exploratory Development at Pharmacia Corp.
from 1950 to 2003.
He was a Director at Hooper Holmes, Inc. from 2007 to 2009 and a Director at Nabi Biopharmaceuticals.
Hudson earned an undergraduate degree in 1968 and a doctorate in 1975 from the University of London.
Precedenti posizioni note di Leslie Hudson
| Società | Posizione | Fine |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Executive Officer | 20/04/2010 |
| HOOPER HOLMES, INC. | Director/Board Member | 29/05/2009 |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | President | 01/07/2006 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Chief Tech/Sci/R&D Officer | 01/01/2003 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/01/1994 |
Formazione di Leslie Hudson
| University of London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 4 |
|---|---|
Hooper Holmes, Inc.
 Hooper Holmes, Inc. Medical/Nursing ServicesHealth Services Hooper Holmes, Inc. provided medical and paramedical examinations for the health insurance industry. The firm offered on-site health screenings, flu shots, laboratory testing, risk assessment and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers. The company was founded by William DeMattos Hooper and Bayard P. Holmes in 1899 and was headquartered in Olathe, KS. | Health Services |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
- Borsa valori
- Insiders
- Leslie Hudson
